ReviewHematology reports2025
Solitary Plasmacytomas: Current Status in 2025.
Review in Hematology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Factors Affecting Prognosis in Patients with Extramedullary Myeloma: A Single-Center Experience.Journal of clinical medicine · 2026Article
- Article
- Solitary Bone Plasmacytoma of Left Wrist Joint - A Case Report.Journal of orthopaedic case reports · 2026Article
- Staged Surgical Resection of Giant Multicentric Cranial Plasma Cell Neoplasms: A Case Report.Cureus · 2026Article
- Solitary extramedullary plasmacytoma of the tongue: a case report.International journal of surgery case reports · 2026Article
- A case of solitary bone plasmacytoma to multiple myeloma: a case report.Frontiers in medicine · 2026Article
- Solitary Plasmacytoma Mimicking Periapical Lesion in Maxillary Teeth: A Case Report.Iranian endodontic journal · 2026Article
- Cervical epidural plasmacytoma causing recurrent radiculopathy and revealing plasma cell leukemia.Surgical neurology international · 2026Article
- Synchronous bone and adrenal extramedullary plasmacytoma: a rare case report and literature review.World journal of surgical oncology · 2025Review
- A Case of Isolated Extramedullary Plasmacytoma of the Sternoclavicular joint: A Rare Case Report.Journal of inflammation research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Solitary plasmacytoma refers to a neoplastic, clonal proliferation of plasma cells forming a single mass. They are divided based on their origin site; solitary bone plasmacytomas originate from the bones, and extramedullary plasmacytomas represent extraosseous tumors. These are rare tumors but carry a risk of transforming to multiple myeloma; thus, optimal management and meticulous follow-up are needed. Their rarity poses a major challenge in conducting large-scale clinical trials, leaving important gaps in evidence regarding best practices. Newer imaging techniques have improved the quality of staging, management decisions, and outcomes. Radiation still has a significant role in treatment algorithms, and adjuvant chemotherapy is gaining more importance; trials are underway in this area. Follow-up should contain biochemical tests as the proposed response definition criteria. We aimed to review the key studies and guidelines in this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.